Ryan Specialty Holdings, Inc. (RYAN) is a specialty insurance services firm that acts as a wholesale broker and managing underwriter for insurance brokers, agents, and carriers. Its analyst coverage is broad but sharply divided, which is why the target used here requires explanation.
The overall average of all tracked 12-month targets is roughly $49, only about 4% above the current price, so it fails the minimum-distance test used for this analysis. The $54 figure is instead the mean of the eight valid targets that sit above the current price: BofA at $67, TD Cowen at $62, Citi at $53.50, UBS and RBC Capital at $52, Morgan Stanley at $50, Keefe Bruyette at $49, and Mizuho at $48. That is a rounded average of about $54.
Below that cluster sit Piper Sandler at $40, JPMorgan at $44 (with an Underweight stance), and Wells Fargo at $46. The spread from $40 to $67 reflects genuine disagreement: bullish analysts cite Ryan's structural share gains in specialty distribution, while more cautious analysts focus on the decelerating organic growth rate and a softening property-and-casualty pricing cycle. None of these targets is a guarantee of future performance. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The latest verified close is about $46.89, within a 52-week range of $29.28 to $58.91. A move to $54 would represent roughly 15% upside, which is a substantial advance requiring both multiple support and continued earnings delivery. The stock trades at a premium trailing P/E ratio near 59, so the path toward $54 depends less on re-rating and more on sustained adjusted-earnings growth and stabilizing organic revenue.
Third-quarter 2026 results showed revenue of $790 million (up 4.7%), adjusted EBITDAC of $244.4 million, and adjusted diluted EPS of $0.51, up 8.5%. Management reaffirmed guidance for organic revenue growth toward the higher end of its mid-single-digit range for 2026 while modestly improving its margin outlook.
The 52-week high of $58.91 and low of $29.28 frame a wide, volatile range. On the way to $54, the stock faces an initial resistance zone around $48 to $50, where several analyst targets and the psychologically important $50 level cluster, followed by the $53 to $55 area. The 52-week high near $59 represents the next major ceiling above the target. On the downside, support sits near $44 to $46, with a firmer floor around the $40 level.
Analyst price targets generally reflect a research horizon of about 12 months, though individual firms apply different assumptions. Investors should watch the fourth-quarter 2026 earnings report, organic revenue growth trends, property pricing conditions, casualty competition, margin trajectory, the pace of buybacks, and any analyst target revisions. Interest-rate decisions and macroeconomic conditions also influence the property-and-casualty cycle.
In my own research, I regularly review Tickeron’s AI Daily Buy/Sell Signals to monitor how market conditions and technical factors are shifting for holdings like this one. The system scans thousands of stocks and ETFs to generate Buy, Sell, or Hold signals based on AI-driven analysis, which helps me stay on top of trends without relying solely on manual checks. It serves as a useful complement when evaluating names with wide analyst ranges and evolving fundamentals.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
RYAN saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 33 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 79%.
The 10-day RSI Indicator for RYAN moved out of overbought territory on November 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 23 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 61 cases where RYAN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 72%.
The Momentum Indicator moved below the 0 level on November 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RYAN as a result. In 59 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RYAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
RYAN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
RYAN moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for RYAN crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +3.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where RYAN advanced for three days, in 200 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 141 of 249 cases where RYAN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. RYAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RYAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RYAN's P/B Ratio (11.438) is slightly higher than the industry average of (2.794). RYAN has a moderately high P/E Ratio (61.192) as compared to the industry average of (19.877). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.322). Dividend Yield (0.011) settles around the average of (0.042) among similar stocks. P/S Ratio (1.707) is also within normal values, averaging (3.106).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InsuranceBrokersServices